About: Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im März 2000 veröffentlicht worden isch (gsw) im März 2000 veröffentlichter wissenschaftlicher Artikel (de) наукова стаття, опублікована в березні 2000 (uk) artículu científicu espublizáu en marzu de 2000 (ast) scientific article published on 01 March 2000 (en)
publication date	wds:Q73594702-FC9AF349-DFE3-44A7-B7B7-D446AE0F68B0
publication date	2000-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73594702-A0F69F82-DDAD-4CD3-B228-35972F7DD12F
language of work or name	English
author name string	wds:Q73594702-0FEE379E-E3F9-4CDE-AD2D-8697D7949D23 wds:Q73594702-15E1972B-A567-453C-A60B-11264F28C90C wds:Q73594702-27B92984-88F7-4B2D-A33F-67321E728466 wds:Q73594702-314EDC19-4ECD-43E9-95B3-6D56DBF6FE33 wds:Q73594702-5F26A243-9A73-40C1-9C82-B65A93B80B28 wds:Q73594702-74EBF112-103C-4A79-B0E7-EC13A59AB4BD wds:Q73594702-7B531820-3583-4604-88B2-8BED2F210851 wds:Q73594702-B20D6305-71C9-45BA-9315-F14E5AB0191A wds:Q73594702-B51B8067-A523-4757-9693-BCE458F8C9E6 wds:Q73594702-C475B4DE-2002-44D2-A9CF-225BA8E20A06 wds:Q73594702-FA6E261B-9CDC-4A46-8095-143476B415CD
author name string	Roy D Dubuc M Lambert J Talajic M Dorian P Green M Eisenberg MJ Connolly S Thibault B Gagné P Kus T
rdfs:label	Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators (en) Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators (nl)
skos:prefLabel	Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators (en) Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators (nl)
name	Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators (en) Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators (nl)
author	wds:Q73594702-24EDEBB1-801A-4C66-A29D-82814A662946
author	Stanley Nattel
title	wds:Q73594702-9846ED38-5384-498B-8DF7-276663848B55
title	Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators (en)
page(s)	wds:Q73594702-7546F04F-9A17-421D-903B-12F61C3618DA
page(s)	913-920
instance of	wds:Q73594702-E0EE9151-E8F4-400D-A060-58D72090CF2A
instance of	scholarly article
main subject	wds:Q73594702-A24F4D41-B2E3-4BB7-9772-F3A29B7290E2 wds:Q73594702-D0FD7E7E-E8D4-4EA4-844F-2A8250188949
main subject	wd:Q410061 atrial fibrillation
PubMed ID	wds:Q73594702-895FBE21-B0FD-4849-97DC-9CFC840650A6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10738049
PubMed ID	10738049
published in	wds:Q73594702-04EA31DF-5112-456B-966D-FC2565D212A2
published in	The New England Journal of Medicine
issue	wds:Q73594702-D4072F95-4115-4E81-9457-665DD72C6F39
volume	wds:Q73594702-7802EF2E-9EA1-4845-97D3-06418B272009
issue	13
volume	342
DOI	wds:Q73594702-E42C452A-FF6B-47B9-8641-9A917E96EF5A
DOI	http://dx.doi.org/10.1056/NEJM200003303421302
DOI	10.1056/NEJM200003303421302
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73594702
is cites work of	Atrial fibrillation in the elderly: facts and management Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Ablation of atrial fibrillation Mechanisms of antiarrhythmic drug actions and their clinical relevance for controlling disorders of cardiac rhythm Evaluation and management of atrial fibrillation Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug Oral vanoxerine prevents reinduction of atrial tachyarrhythmias: preliminary results Controversies in atrial fibrillation Trends in catheter ablation for atrial fibrillation in the United States Catheter ablation versus anti-arrhythmic drug therapy for the management of a trial fibrillation: a meta-analysis 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society Progress in nonpharmacologic therapy of atrial fibrillation Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study Surgery for atrial fibrillation Novel anti-arrhythmic medications in the treatment of atrial fibrillation Drug therapy for atrial fibrillation: where do we go from here? Drug therapy in atrial fibrillation management: where do we stand in 2010? A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology Pacing for atrial fibrillation Drug therapy for atrial fibrillation Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment Atrial fibrillation therapy now and in the future: drugs, biologicals, and ablation New antiarrhythmic drugs for treatment of atrial fibrillation. Rhythm control for management of patients with atrial fibrillation: balancing the use of antiarrhythmic drugs and catheter ablation. Atrial fibrillation and heart failure in the elderly The incidence and predictors of overall adverse effects caused by low dose amiodarone in real-world clinical practice Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software